Compare AMPY & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMPY | QTRX |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.8M | 160.0M |
| IPO Year | 2011 | 2017 |
| Metric | AMPY | QTRX |
|---|---|---|
| Price | $4.38 | $3.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $7.75 | $3.00 |
| AVG Volume (30 Days) | 478.5K | ★ 836.1K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 232.26 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $208,637,000.00 | $37,632,000.00 |
| Revenue This Year | N/A | $3.55 |
| Revenue Next Year | $5.75 | $10.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $3.65 | $2.15 |
| 52 Week High | $6.79 | $8.77 |
| Indicator | AMPY | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.06 | 67.82 |
| Support Level | $3.86 | $3.31 |
| Resistance Level | $5.07 | $3.99 |
| Average True Range (ATR) | 0.14 | 0.22 |
| MACD | -0.06 | 0.11 |
| Stochastic Oscillator | 12.31 | 96.30 |
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.